CDC25A and chronic myelogenous leukemia, BCR-ABL1 positive: Future experiments involving miR-122-5p mimic/inhibitor transfection and CDC25A silencing or overexpression will be performed to verify their direct effects on cell cycle progression, proliferation, and apoptosis in CML models.